Incyte develops a wide range of therapeutics, primarily for oncology. Benchling supports their antibody discovery group.
Number of employees: 1001 – 5000
Location: Wilmington, DE, USA
Lack of a central informatics solution
Incyte’s antibody discovery group was starting from the ground-up and knew it would be pivotal to deploy a world-class informatics system as soon as possible.
Difficulty in tracking experimental results and progress
With a growing team and fluid processes, the antibody discovery group needed a flexible system, or else their data would be unreliable and difficult to track.
Collaborating across intercontinental sites without a shared system
Being able to work with external collaborators (including international collaborators) was a must.